10/17/2024
5:39 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
5:42 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
5:01 PM | Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
4:19 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
09/09/2024
3:33 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:23 PM | Ionis Pharmaceuticals (Filer)
| Form 424B5 | |
|
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:43 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:51 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:23 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
09/04/2024
8:24 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144/A | |
09/04/2024
8:25 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:27 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:29 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:33 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/04/2024
8:33 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
09/04/2024
8:40 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:40 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:41 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
8:19 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144/A | |
09/04/2024
8:20 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144/A | |
09/04/2024
8:21 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
8:02 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4/A | |
09/04/2024
8:06 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4/A | |
09/04/2024
8:11 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4/A | |
09/04/2024
8:13 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/04/2024
7:51 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4/A | |
09/04/2024
7:52 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4/A | |
09/04/2024
7:42 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/04/2024
7:42 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4/A | |
09/03/2024
6:18 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
4:27 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
2:35 PM | Ionis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
4:02 PM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:02 PM | Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:02 PM | HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:02 PM | Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:03 PM | Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:03 PM | Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Sell NVDA Now? (Ad) Guess who's selling NVDA next
The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). |
07/17/2024
4:03 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:11 PM | Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
2:13 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4/A | |
07/03/2024
1:48 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:48 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:47 PM | Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:52 PM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:29 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
9:59 AM | BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:33 PM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
6:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
4:25 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:55 PM | Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:50 PM | Ionis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:52 PM | Ionis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:53 PM | Ionis Pharmaceuticals (Filer)
| Form ARS | |
04/17/2024
4:16 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
4:19 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
7:59 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
7:50 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
5:04 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:52 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
4:52 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
8:10 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:38 PM | Ionis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2024
10:17 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
9:39 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
02/16/2024
6:47 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:34 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
5:09 AM | BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
6:54 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:54 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:54 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
02/02/2024
4:31 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:34 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:21 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:23 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:25 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:28 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:30 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:19 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
9:27 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
